Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Long Term Eff Med Implants ; 14(5): 415-30, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15479155

RESUMO

People are exposed to ambient solar ultraviolet (UV) radiation throughout their daily routine, intentionally and unintentionally. Cumulative and excessive exposure to UV radiation is the behavioral cause to skin cancers, skin damage, premature skin aging, and sun-related eye disorders. More than one million new cases of skin cancer were diagnosed in the United States this year. UV radiates directly and diffusely scattered by the various environmental and atmospheric conditions and has access to the skin from all directions. Because of this diffuse UV radiation, a person situated under a covering, such as the roof of a car or house, is not completely protected from the sun's rays. Because shade structures do not protect effectively against UV radiation, there have been major advances in photoprotection of glass by the development of specially designed photoprotective windows and films. It is the purpose of this collective review to highlight the photoprotective windows and films that should be incorporated into residential, commercial, and school glass windows to reduce sun exposure. Low-emittence (low-E) coatings are microscopically thin, virtually invisible, metal or metallic oxide layers deposited on a window or skylight glazing surface to reduce the U-factor by suppressing radiative heat flow as well as to limit UV radiation. The exclusive Thermaflect coating uses the most advanced, double-layer soft coat technology to continue to deliver top performance for UV protection as well as prevent heat loss in the home. This product blocks 87% of UV radiation and has an Energy Star certification in all climate zones. Tints and films have been another important advance in glass photoprotection, especially in automobiles. Quality widow film products are high-tech laminates of polyester and metallized coatings bonded by distortion-free adhesives. The International Window Film Association provides members with accreditation in solar control films, safety films, and automotive films in an effort to increase consumer awareness and demand for all professionally installed film window products. The Skin Cancer Foundation has also played a leadership role in certifying window films that limit UV transmission. The Panorama Designer and Safety Films are currently recommended for UV photoprotection by The Skin Cancer Foundation. On the basis of these innovative scientific and industrial advances in window and film photoprotective products, we recommend that they be used in all residential, commercial, and school facilities to provide photoprotection in an effort to reduce skin cancer.


Assuntos
Vidro , Habitação , Neoplasias Cutâneas/prevenção & controle , Raios Ultravioleta , Humanos
2.
J Long Term Eff Med Implants ; 14(4): 317-40, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15447629

RESUMO

Skin cancer is the most common cancer diagnosed in the United States, and its incidence continues to rise. Epidemiological studies have documented that excessive sun exposure increases the risk of developing nonmelanoma skin cancer. Consequently, it is mandatory that the skin be protected from the damage that occurs from ultraviolet (UV) exposure. It is the purpose of this report to review the scientific basis for photoprotection by sunscreens, topical antioxidants, and systemic antioxidants to minimize the harmful effect of sun exposure. The US Food and Drug Administration regulates sunscreen products as over-the-counter drugs. Sunscreens are chemical or organic UV absorbers and nonchemical or inorganic UV absorbers. Other important sunscreen considerations include the sunscreen vehicle, sunscreen photostability, sunscreen preservatives, and sunscreen photoallergy and phototoxicity. Topical and systemic antioxidants have now been shown to supplement the photoprotective effects of sunscreen. The Skin Cancer Foundation, the only national and international nonprofit organization concerned exclusively with cancer of the skin, is playing a leadership role in eliminating skin cancer in our world.


Assuntos
Corticosteroides/uso terapêutico , Antioxidantes/uso terapêutico , Neoplasias Cutâneas/prevenção & controle , Protetores Solares/uso terapêutico , Administração Tópica , Corticosteroides/administração & dosagem , Antioxidantes/administração & dosagem , Relação Dose-Resposta à Radiação , Humanos , Neoplasias Cutâneas/tratamento farmacológico , Neoplasias Cutâneas/etiologia , Raios Ultravioleta/efeitos adversos
3.
J Long Term Eff Med Implants ; 14(3): 215-24, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15301665

RESUMO

Australia has developed a national health care policy that has made prevention of the occurrence of skin cancer a societal responsibility. Its strategies for skin cancer control have included careful documentation of the incidence of skin cancer over the last two decades. After realizing that the magnitude of sun exposure during childhood is a major risk factor in the development of skin cancer, Australia provides successful strategies to monitor and reduce the frequency of skin cancer. Early in the 1970s, education campaigns for the public as well as the healthcare worker were implemented that included booklets, posters, and teaching materials. This educational program allowed the public as well as healthcare workers to diagnose accurately the presence of skin cancer. In addition to identifying tumors at an early stage, Australia managed an exciting educational program on photodamage prevention. Australian standards governing ultraviolet radiation protection were incorporated into numerous comprehensive legislative bills that set standards for a wide variety of sun protective products to include sunscreens, photoprotective apparel, sunglasses, and occupational standards for sun exposure. On the basis of these comprehensive standards, the epidemic of skin cancer has been curbed, as documented. In contrast to Australia, the United States has relatively few comprehensive skin cancer prevention programs. These programs include the National Skin Cancer Prevention Educational Program, National Skin Cancer Prevention and Detection Month, The Skin Cancer Foundation's Self-Examination Program, and the State of California and US Food and Drug Administration Sunscreen legislation. It is difficult to measure the impact of these innovative efforts because there is not an accurate monitoring system for all skin cancers in the United States. However, the National Cancer Institute does determine the incidence of melanoma, which is reported annually by the American Cancer Society in their January/February issue of CA Journal for Clinicians. Statistics on other skin cancers are only projective. In the absence of an accurate, comprehensive statistical monitoring system for the frequency of skin cancer in the United States, as well as the limited legislative initiatives, it is difficult for organizations such as the American Academy of Dermatology, the American Cancer Society, the Centers for Disease Control and Prevention, and The Skin Cancer Foundation to ascertain the results of their efforts to prevent skin cancer. Consequently, the prevention of skin cancer in the United States is a personal rather than a societal responsibility.


Assuntos
Educação em Saúde/organização & administração , Melanoma/prevenção & controle , Medicina Preventiva/métodos , Neoplasias Cutâneas/prevenção & controle , Luz Solar/efeitos adversos , Austrália/epidemiologia , Feminino , Planejamento em Saúde/organização & administração , Humanos , Masculino , Melanoma/epidemiologia , Neoplasias Cutâneas/epidemiologia , Protetores Solares/uso terapêutico , Raios Ultravioleta/efeitos adversos , Estados Unidos/epidemiologia
4.
J Long Term Eff Med Implants ; 14(2): 95-106, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15099187

RESUMO

For many years, individuals around the world have relied on sunscreen alone as their primary form of protection against ultraviolet rays (UV-R). Australia has shown that a multitactic approach to skin cancer prevention, combining sun-protective clothing with sunscreen, can be both highly effective and widely accepted by the general public. In the US, the aging baby boomer generation and rising skin cancer epidemic call for a fundamental behavioral shift toward this combination approach to sun protection. Sun-protective clothing, such as that manufactured by Coolibar and awarded the Seal of Recommendation by The Skin Cancer Foundation, offers millions of Americans the opportunity to significantly improve the quality of their lives and is an essential step in eliminating skin cancer in our world. All Coolibar clothing products carry a minimum ultraviolet protection factor (UPF) rating of 30, blocking 97% UV-R or greater. Each product in the Coolibar clothing line is individually tested and rated for its UV protection level; this process is explained in a thorough hangtag attached to the product. This tag specifies what UPF the product has received, how the UPF is figured, which testing procedures the individual product was submitted to, and if that product has received the Seal of Recommendation from The Skin Cancer Foundation. In addition to photoprotective clothing, The Skin Cancer Foundation recommends Rit Sun Guard, a photoprotective laundry additive. Rit Sun Guard washes into the clothing fibers and absorbs broadband UV-R. A single treatment of Rit Sun Guard sustains a UPF of 30 for approximately 20 launderings. The active ingredient in Rit Sun Guard is TINOSORB FD. In order to be certified by The Skin Cancer Foundation, the Coolibar clothing product must undergo extensive UPF testing to confirm the accuracy of the product labeling. Laundry additives evaluated by The Skin Cancer Foundation undergo similar tests to that of photoprotective clothing after a uniform laundering method is used to apply the product to the clothing fibers. Both of these certification processes confirm the UPF, UV-A and UV-B transmittance, and percentage blocking UV-A and UV-B. The certification process is reviewed on an annual basis.


Assuntos
Roupa de Proteção/tendências , Neoplasias Cutâneas/prevenção & controle , Queimadura Solar/prevenção & controle , Promoção da Saúde , Humanos
5.
J Long Term Eff Med Implants ; 13(3): 139-54, 2003.
Artigo em Inglês | MEDLINE | ID: mdl-14516181

RESUMO

The World Health Organization was committed to eliminating neonatal tetanus by 1995. Three years after this date, the infection killed over 400,000 babies a year, even though a safe, effective vaccine had been available for most of this century. The frequency of tetanus in the developing world epitomizes the healthcare disparity between the developed and the developing world. Consequently, the priority of the medical profession must be prevention, with the development of simpler immunization schedules with longer protection. Consequently, the purpose of this collective review is to provide an overview to the management of tetanus as well as to review the immunization strategy that will prevent this potentially deadly illness. Tetanus is caused by Cloistridium tetani, which is an obligate anaerobic, gram-positive rod that is motile and readily forms endospores. Although C. tetani is located everywhere, the disease is encountered largely in underdeveloped, overcrowded, and economically disadvantaged countries. C. tetani is widespread in the feces of domestic animals and humans, while spores of C. tetani are abundant in soil and in the environment surrounding the habitation of humans and animals. Tetanus usually follows deep penetrating wounds where anaerobic bacterial growth is facilitated. Three basic forms of tetanus may be distinguished: local, cephalic, and generalized. At least 80% of the cases are the generalized form. In the adult patient, the most characteristic sign of generalized tetanus is lockjaw, or trismus. The diagnosis of tetanus is most frequently made on clinical manifestations, rather than on bacteriologic findings. The three objectives of management of tetanus are: (1) to provide supportive care until the tetanospasmin that is fixed in tissue has been metabolized; (2) to neutralize circulating toxin; and (3) to remove the source of tetanospasmin. Because there is essentially no immunity to tetanus toxoid, the only effective way to control tetanus is by prophylactic immunization.


Assuntos
Antibacterianos/uso terapêutico , Toxoide Tetânico/uso terapêutico , Tétano , Adulto , Idoso , Animais , Antibacterianos/efeitos adversos , Criança , Clostridium tetani/patogenicidade , Humanos , Esquemas de Imunização , Lactente , Recém-Nascido , Pessoa de Meia-Idade , Índice de Gravidade de Doença , Tétano/tratamento farmacológico , Tétano/fisiopatologia , Tétano/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...